Liminatus Pharma announces annual shareholder meeting

Liminatus Pharma

Liminatus Pharma

LIMN

0.00
  • Liminatus Pharma will hold its annual shareholder meeting in Fullerton, California in July 2026.
  • Shareholders will vote to elect two directors: Nicholas Fernandez, Dr. Ji Yeon Baek.
  • A proposal seeks shareholder authorization for a reverse stock split of up to 1-for-50, with the final ratio set by the board.
  • Investors will also vote on a charter amendment to reflect the reverse stock split.
  • Another item asks shareholders to ratify WithumSmith+Brown as independent auditor for fiscal 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Liminatus Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-078994), on June 30, 2026, and is solely responsible for the information contained therein.

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.